Chemical biology--identification of small molecule modulators of cellular activity by natural product inspired synthesis.
暂无分享,去创建一个
Herbert Waldmann | H. Waldmann | K. Hübel | Katja Hübel | Torben Lessmann | T. Lessmann | Torben Lessmann
[1] B. Suter,et al. Yeast-based functional genomics and proteomics technologies: the first 15 years and beyond. , 2006, BioTechniques.
[2] S. Danishefsky,et al. Small molecule natural products in the discovery of therapeutic agents: the synthesis connection. , 2006, The Journal of organic chemistry.
[3] A Ganesan,et al. Natural products as a hunting ground for combinatorial chemistry. , 2004, Current opinion in biotechnology.
[4] H. Waldmann,et al. Solid-Phase Synthesis and Biological Evaluation of a Teleocidin Library—Discovery of a Selective PKCδ Down Regulator , 2000 .
[5] H. Waldmann,et al. Stereocomplementary synthesis of a natural product-derived compound collection on a solid phase. , 2006, Chemical communications.
[6] Â. de Fátima,et al. (R)-Goniothalamin: total syntheses and cytotoxic activity against cancer cell lines. , 2005, Bioorganic & medicinal chemistry.
[7] H. Osada,et al. Photo-cross-linked small-molecule affinity matrix for facilitating forward and reverse chemical genetics. , 2005, Angewandte Chemie.
[8] B. Stockwell. Exploring biology with small organic molecules , 2004, Nature.
[9] C. Forsyth,et al. Phorboxazole analogues induce association of cdk4 with extranuclear cytokeratin intermediate filaments. , 2006, Journal of the American Chemical Society.
[10] L. Meijer,et al. Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography , 2007, Biotechnology journal.
[11] P. Arya,et al. Toward high-throughput synthesis of complex natural product-like compounds in the genomics and proteomics age. , 2002, Chemistry & biology.
[12] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[13] Y. Feng,et al. Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of the natural product. , 2001, Journal of the American Chemical Society.
[14] Kevin Barraclough,et al. I and i , 2001, BMJ : British Medical Journal.
[15] Gisbert Schneider,et al. Properties and Architecture of Drugs and Natural Products Revisited , 2007 .
[16] Miklos Feher,et al. Property Distributions: Differences between Drugs, Natural Products, and Molecules from Combinatorial Chemistry , 2003, J. Chem. Inf. Comput. Sci..
[17] David R Spring,et al. Chemical genetics to chemical genomics: small molecules offer big insights. , 2005, Chemical Society reviews.
[18] J. Wölcke,et al. Miniaturized HTS technologies - uHTS. , 2001, Drug discovery today.
[19] M Elofsson,et al. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. , 2001, Chemistry & biology.
[20] Stefan Wetzel,et al. The Scaffold Tree - Visualization of the Scaffold Universe by Hierarchical Scaffold Classification , 2007, J. Chem. Inf. Model..
[21] Hendrik Luesch,et al. Towards high-throughput characterization of small molecule mechanisms of action. , 2006, Molecular bioSystems.
[22] Stefan Wetzel,et al. Cheminformatic Analysis of Natural Products and their Chemical Space , 2007 .
[23] H. Waldmann,et al. Enantioselective synthesis on the solid phase. , 2006, Chemical Communications.
[24] R. S. Shaw,et al. α-Pyrones and their derivatives from two Cryptocarya species , 1995 .
[25] Herbert Waldmann,et al. From protein domains to drug candidates – natural products as guiding principles in , 2002 .
[26] Herbert Waldmann,et al. Compound library development guided by protein structure similarity clustering and natural product structure. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[27] Dalia Cohen,et al. Functional genomics to new drug targets , 2004, Nature Reviews Drug Discovery.
[28] G. Terstappen,et al. Target deconvolution strategies in drug discovery , 2007, Nature Reviews Drug Discovery.
[29] Xiaofeng S Zheng,et al. Genetic and genomic approaches to identify and study the targets of bioactive small molecules. , 2004, Chemistry & biology.
[30] A. Schuffenhauer,et al. Charting biologically relevant chemical space: a structural classification of natural products (SCONP). , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] W Patrick Walters,et al. Prediction of 'drug-likeness'. , 2002, Advanced drug delivery reviews.
[32] Timothy J Mitchison,et al. Small‐Molecule Screening and Profiling by Using Automated Microscopy , 2005, Chembiochem : a European journal of chemical biology.
[33] D. Boger,et al. Fostriecin: chemistry and biology. , 2002, Current medicinal chemistry.
[34] F. Koehn,et al. The evolving role of natural products in drug discovery , 2005, Nature Reviews Drug Discovery.
[35] H. Waldmann,et al. Natural products are biologically validated starting points in structural space for compound library development: solid-phase synthesis of dysidiolide-derived phosphatase inhibitors. , 2002, Angewandte Chemie.
[36] K. Nishikawa,et al. The Anticancer Natural Product Pironetin Selectively Targets Lys352 of α-Tubulin , 2004 .
[37] N. Shimada,et al. Pironetin, a novel plant growth regulator produced by Streptomyces sp. NK10958. I. Taxonomy, production, isolation and preliminary characterization. , 1994, The Journal of antibiotics.
[38] Brian J Eastwood,et al. A Comparison of Assay Performance Measures in Screening Assays: Signal Window, Z' Factor, and Assay Variability Ratio , 2006, Journal of biomolecular screening.
[39] Paul A Wender,et al. Function-oriented synthesis, step economy, and drug design. , 2008, Accounts of chemical research.
[40] John B. Shoven,et al. I , Edinburgh Medical and Surgical Journal.
[41] Herbert Waldmann,et al. Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[42] B. Cravatt,et al. Protein-reactive natural products. , 2005, Angewandte Chemie.
[43] Christopher T. Walsh,et al. Lessons from natural molecules , 2004, Nature.
[44] L. Burdine,et al. Target identification in chemical genetics: the (often) missing link. , 2004, Chemistry & biology.
[45] Jun O. Liu,et al. Simultaneous arming and structure/activity studies of natural products employing O-H insertions: an expedient and versatile strategy for natural products-based chemical genetics. , 2007, Journal of the American Chemical Society.
[46] E J Licitra,et al. A three-hybrid system for detecting small ligand-protein receptor interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[47] Stuart L Schreiber,et al. A planning strategy for diversity-oriented synthesis. , 2004, Angewandte Chemie.
[48] Introduction to Chemical Proteomics for Drug Discovery and Development , 2007, Archiv der Pharmazie.
[49] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[50] H. Waldmann,et al. An Enzyme-Labile Linker Group for Organic Syntheses on Solid Supports. , 1998, Angewandte Chemie.
[51] G. Schneider,et al. Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. , 2001, Journal of combinatorial chemistry.
[52] Derek S. Tan,et al. Advancing chemistry and biology through diversity-oriented synthesis of natural product-like libraries. , 2005, Current opinion in chemical biology.
[53] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[54] Harald Schwalbe,et al. Identification of inhibitors for mycobacterial protein tyrosine phosphatase B (MptpB) by biology-oriented synthesis (BIOS). , 2007, Chemistry, an Asian journal.
[55] Anang A Shelat,et al. Scaffold composition and biological relevance of screening libraries. , 2007, Nature chemical biology.
[56] Christopher P Austin,et al. High-throughput screening assays for the identification of chemical probes. , 2007, Nature chemical biology.
[57] Herbert Waldmann,et al. From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries. , 2002, Angewandte Chemie.
[58] D. Pereira,et al. Origin and evolution of high throughput screening , 2007, British journal of pharmacology.
[59] D. Newman,et al. Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.
[60] Elizabeth A. Winzeler,et al. Genomic profiling of drug sensitivities via induced haploinsufficiency , 1999, Nature Genetics.
[61] Herbert Waldmann,et al. Natural product-derived modulators of cell cycle progression and viral entry by enantioselective oxa Diels-Alder reactions on the solid phase. , 2007, Chemistry & biology.
[62] E. Jacoby,et al. Chemogenomics: an emerging strategy for rapid target and drug discovery , 2004, Nature Reviews Genetics.
[63] H. Waldmann,et al. Organic Synthesis and Biological Signal Transduction , 1998, Angewandte Chemie.
[64] David J Newman,et al. Natural products as sources of new drugs over the period 1981-2002. , 2003, Journal of natural products.
[65] Steven V. Ley,et al. New tools and concepts for modern organic synthesis , 2002, Nature Reviews Drug Discovery.
[66] H. Waldmann,et al. Synthesis and biological evaluation of an indomethacin library reveals a new class of angiogenesis-related kinase inhibitors. , 2004, Angewandte Chemie.
[67] D G Hall,et al. Solution- and solid-phase strategies for the design, synthesis, and screening of libraries based on natural product templates: a comprehensive survey. , 2001, Journal of combinatorial chemistry.
[68] Waldmann,et al. Natural Product Synthesis on Polymeric Supports-Synthesis and Biological Evaluation of an Indolactam Library. , 1999, Angewandte Chemie.